Found 12 matching trials
Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) PHASE3 The purpose of this study is to evaluate the efficacy and gather additional...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease N/A Protocol 620 provides PROCHYMAL(R) adult human mesenchymal cells to specifi...
Show More Status
No Longer Available
Location
Unviersity of California, San Francisco
Learn More & Join Trial
Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD) N/A This protocol allows for the treatment of patients, male and female, betwee...
Show More Status
No Longer Available
Learn More & Join Trial
Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) N/A The objectives of this intermediate-size expanded access protocol are to as...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD N/A This protocol allows for the treatment of pediatric patients, male and fema...
Show More Status
No Longer Available
Location
Phoenix Children's Hospital
Learn More & Join Trial
Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI) PHASE2 The objective of the present study is to establish the safety and efficacy ...
Show More Location
Mercy Gilbert Medical Center / Catholic Health Care West
Learn More & Join Trial
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) PHASE2 The purpose of this study is to establish the safety and efficacy of multip...
Show More Location
University of Alabama, Division of Endocrinology & Metabolism
Learn More & Join Trial
Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) PHASE3 This is a Phase III, randomized, double-blind, placebo-controlled study to ...
Show More Location
University of Alabama Birmingham (UAB) Hospital
Learn More & Join Trial
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) PHASE2 To establish the safety and efficacy of two dose levels of ex-vivo cultured...
Show More Location
St. Francis Hospital
Learn More & Join Trial
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease PHASE3 To provide open-label re-treatment with PROCHYMAL to participants enrolled ...
Show More Location
University of California, San Francisco
Learn More & Join Trial